Weight-loss drugs could reduce COVID-related deaths: Study
Patients taking the weight-loss drug semaglutide were less likely to die from COVID-19, according to a recent study. The patients who contracted COVID-19 while using a weekly 2.4 mg dose of semaglutide, the active ingredient in Novo Nordisk’s Wegovy and Ozempic, had a 34% lower risk of dying from COVID-19, according to Dr. Benjamin M. Scirica, one … Read more